Metabolomic fingerprinting of dialysis patients for early detection of vascular calcification

Authors

  • Bhuneshwari Dewangan
  • Moniza Nurez Khan

DOI:

https://doi.org/10.65327/kidneys.v14i4.563

Keywords:

biomarkers; dialysis; metabolomics; principal component analysis; receiver operating characteristic; vascular calcification

Abstract

Vascular calcification (VC) is one of the dreaded long-term dialysis complications. Its effect
on cardiac morbidity and mortality is still appalling and sadly undervalued. The inefficiency and absence
of modern methods of diagnosis are also illogical reasons for the distress of the health system. It implies
distressing the potential opportunity cost by early diagnosis. The research aimed to alleviate pain in patients
with VC and dialysis by targeting early diagnosis using new metabolomic techniques. The samples and
serum samples following LCM were gathered, normalized, and established by pre-treatment multivariate
statistical methods of principal component analysis and partial least squares discriminant analysis.
The metabolic profiles of VC patients and non-VC patients exhibited typical patterns. Apart from that,
understanding precisely which biomarkers it utilized actually had proper diagnostic accuracy because it
is noted in sensitivity, specificity, and AUC results. It was found that metabolomic fingerprinting is a potent
tool, which consequently implies that the current invasive diagnostic methods for VC in dialysis patients
must be put on the shelf in favor of a less invasive technique. It is also recommended as a second tool to
complement the pre- and post-diagnosis reaction to the VC.

Downloads

Download data is not yet available.

Author Biographies

Bhuneshwari Dewangan

Kalinga University, Raipur, India

Moniza Nurez Khan

Kalinga University, Raipur, India

References

Siracusa C, Carabetta N, Morano MB, Manica M, Strangio A, et al. Understanding vascular calcification in chronic kidney

disease: pathogenesis and therapeutic implications. Int J Mol Sci.

;25(23):13096. doi: 10.3390/ijms252313096.

Vij P, Prashant PM. Predicting aquatic ecosystem health

using machine learning algorithms. Int J Aquat Res Environ Stud.

;4(S1):39-44. doi: 10.70102/ijares/v4s1/7.

Li Q, Li P, Xu Z, et al. Association of diabetes with cardiovascular calcification and all-cause mortality in end-stage renal disease

in the early stages of hemodialysis: a retrospective cohort study. Cardiovasc Diabetol. 2024;23:259. doi: 10.1186/s12933-024-02318-8.

Jagadeeswaran, Logeswaran, Prasath S, Thiyagarajan,

Naga rajan. Machine learning model to detect the liver disease. Int

Acad J Innov Res. 2022;9(1):6-12. doi: 10.9756/iajir/v9i1/iajir0902.

Izzo C, Secondulfo C, Bilancio G, Visco V, Virtuoso N, et al.

Chronic kidney disease with mineral bone disorder and vascular calcification: an overview. Life. 2024;14(3):418. doi: 10.3390/life14030418.

Mendes C, Petrova O. Terminology mapping in health information exchanges: a case study on ICD and LOINC integration. Glob

J Med Terminol Res Inform. 2024;2(2):18-21.

Wang W, Kou J, Long J, et al. GC/MS and LC/MS serum

metabolomic analysis of Chinese LN patients. Sci Rep. 2024;14:1523.

doi: 10.1038/s41598-024-52137-w.

Kumar TMS. Comparative analysis of Hatha yoga and aerobic exercise on cardiovascular health in middle-aged adults. J Yoga

Sports Health Sci. 2025;1(1):9-16.

Jin Q, Lau ESH, Luk AO, et al. Circulating metabolomic

markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes

Biobank. Diabetologia. 2024;67:837-849. doi: 10.1007/s00125-024-

-5.

Suresh A, Narayanan R. Impact of salivary biomarkers on

early detection of periodontitis in geriatric patients. Clin J Med Health

Pharm. 2025;3(1):8-13.

Yang K, Zhang P, Ding X, et al. Integrating bioinformatics and

metabolomics to identify potential biomarkers of hypertensive nephropathy. Sci Rep. 2025;15:7437. doi: 10.1038/s41598-025-89601-0.

Heuschkel MA, Jaminon A, Gräber S, Artati A, Adamski J,

et al. Hypotaurine reduces glucose-mediated vascular calcification.

Acta Physiol. 2025;241(8):e70075. doi: 10.1111/apha.70075.

Liu Y, Sun M, Sun J, Lin F, Xu D, et al. Identification of

novel serum metabolic signatures to predict chronic kidney disease

among Chinese elders using UPLC-Orbitrap-MS. J Nutr Health

Aging. 2024;28(3):100036. doi: 10.1016/j.jnha.2023.100036.

Benito S, Unceta N, Maciejczyk M, et al. Revealing novel

biomarkers for diagnosing chronic kidney disease in pediatric patients.

Sci Rep. 2024;14:11549. doi: 10.1038/s41598-024-62518-w.

Santana E, Ibrahimi E, Ntalianis E, Cauwenberghs N,

Kuznetsova T. Integrating metabolomics domain knowledge with

explainable machine learning in atherosclerotic cardiovascular disease classification. Int J Mol Sci. 2024;25(23):12905. doi: 10.3390/

ijms252312905.

Geng C, Liang B, Kong Z, Feng L, Wang J, et al. Metabolomic profiling reveals biomarkers in coronary heart disease comorbidity. J Diabetes Res. 2024;2024(1). doi: 10.1155/jdr/8559677.

Lee J, Gilliland T, Dron J, Koyama S, Nakao T, et al. Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks. Arterioscler

Thromb Vasc Biol. 2024;44(9):2108-2117. doi: 10.1161/atvbaha.124.321282.

Nazir A, Nazir A, Afzaal U, Aman S, Sadiq SUR, et al. Advancements in biomarkers for early detection and risk stratification

of cardiovascular diseases — a literature review. Health Sci Rep.

;8(5):e70878. doi: 10.1002/hsr2.70878.

Ortega MA, De Leon-Oliva D, Gimeno-Longas MJ, Boaru DL, Fraile-Martinez O, et al. Vascular calcification: molecular

networking, pathological implications and translational opportunities.

Biomolecules. 2024;14(3):275. doi: 10.3390/biom14030275.

Van Roy N, Speeckaert MM. The potential use of targeted

proteomics and metabolomics for the identification and monitoring of

diabetic kidney disease. J Pers Med. 2024;14(10):1054. doi: 10.3390/

jpm14101054.

Neofytou IE, Stamou A, Demopoulos A, Roumeliotis S,

Zebekakis P, et al. Vitamin K for vascular calcification in kidney

patients: still alive and kicking, but still a lot to learn. Nutrients.

;16(12):1798. doi: 10.3390/nu16121798.

Zaslow SJ, Oliveira-Paula GH, Chen W. Magnesium and

vascular calcification in chronic kidney disease: current insights. Int J

Mol Sci. 2024;25(2):1155. doi: 10.3390/ijms25021155.

Fang Y, Zhao Y, Huang J, Yang X, Liu Y, Zhang X. The

functional role of cellular senescence during vascular calcification

in chronic kidney disease. Front Endocrinol. 2024;15. doi: 10.3389/

fendo.2024.1330942.

Gu X, Dong Y, Wang X, Ren Z, Li G, et al. Identification of

serum biomarkers for chronic kidney disease using serum metabolomics. Ren Fail. 2024;46(2). doi: 10.1080/0886022x.2024.2409346.

Chiu KJ, Chen SC, Su WY, et al. The association of peritoneal dialysis and hemodialysis on mitral and aortic valve calcification

associated mortality: a meta-analysis. Sci Rep. 2024;14:4748. doi:

1038/s41598-024-55326-9.

Downloads

Published

2025-11-15

How to Cite

Bhuneshwari Dewangan, & Moniza Nurez Khan. (2025). Metabolomic fingerprinting of dialysis patients for early detection of vascular calcification. KIDNEYS, 14(4), 306–312. https://doi.org/10.65327/kidneys.v14i4.563

Issue

Section

Research Article